Back to School: How biopharma can reboot drug development. Access exclusive analysis here

Batimastat matrix metalloproteinase inhibitor: Began Phase II trial

British Bio-technology Group plc (BBIOY), U.K.
Product: Batimastat matrix metalloproteinase inhibitor,

Read the full 114 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE